# [Feline Upper Respiratory Infections](/knowledge/bacteria/pet-bacteria/feline-upper-respiratory-infections-causes-transmission-and-treatment): Bacterial Pathogens and Diagnostic Approaches
## Key Takeaways
- Feline upper respiratory infections (URIs) are multifactorial, with viral agents like FHV-1 and FCV often initiating disease, followed by bacterial pathogens that exacerbate damage and prolong illness.
- Primary bacterial pathogens include *Bordetella bronchiseptica* (Gram-negative coccobacillus causing tracheobronchitis), *Chlamydia felis* (obligate intracellular bacterium causing conjunctivitis), and *Mycoplasma felis* (cell wall-deficient bacterium associated with sneezing and conjunctivitis).
- Diagnostic approaches integrate clinical examination with sample collection (nasal/conjunctival swabs) for cytology, bacterial culture with antimicrobial susceptibility testing, and molecular diagnostics such as PCR, which is the gold standard for fastidious or intracellular bacteria.
- High-density housing (shelters, catteries) and stress are significant risk factors for bacterial URI, with young age and concurrent viral or immunosuppressive infections further increasing susceptibility.
- Treatment often involves empirical antimicrobial therapy, with doxycycline being a first-line choice for *B. bronchiseptica*, *C. felis*, and *M. felis*, but antimicrobial resistance necessitates susceptibility testing for effective management.
- Prevention strategies in multi-cat environments focus on reducing stress, improving ventilation, cohort isolation, and appropriate disinfection; vaccination against *B. bronchiseptica* and *C. felis* may be indicated in high-risk populations.
---
## Introduction
[Feline upper respiratory infections](/knowledge/bacteria/pet-bacteria/feline-upper-respiratory-infections-causes-transmission-and-treatment) (URI) represent a multifactorial disease complex in which viral and bacterial agents interact to produce clinical signs involving the nasal cavity, pharynx, larynx, and conjunctiva [1]. While viruses such as feline herpesvirus-1 (FHV-1) and [feline calicivirus](/knowledge/viruses/pet-viruses/feline-calicivirus) (FCV) are primary inciting agents, secondary or primary bacterial pathogens frequently exacerbate tissue damage and prolong disease [2]. Understanding the bacterial component of [[cat bacterial respiratory infection](/knowledge/bacteria/pet-bacteria/bacterial-respiratory-infections-cats-etiology-clinical-treatment)] is essential for appropriate antimicrobial stewardship, accurate diagnosis, and effective outbreak management. This article reviews the major bacterial pathogens, their epidemiology, clinical presentation, diagnostic approaches, and control strategies within the context of feline medicine.
## Primary Bacterial Pathogens
The most commonly isolated bacteria from cats with acute or chronic URI include *[Bordetella bronchiseptica](/knowledge/bacteria/pet-bacteria/bordetella-bronchiseptica)*, *Chlamydia felis*, and *Mycoplasma felis* [1, 2]. Less frequently, *Streptococcus equi* subsp. *zooepidemicus*, *Pasteurella multocida*, *Escherichia coli*, and *Klebsiella* species are identified as opportunistic invaders [3]. Each pathogen exhibits distinct biological properties that influence diagnostic targeting and treatment.
### [Bordetella bronchiseptica](/knowledge/bacteria/pet-bacteria/bordetella-bronchiseptica)
*Bordetella bronchiseptica* is a Gram-negative, aerobic coccobacillus that colonizes the ciliated respiratory epithelium of multiple mammalian hosts including cats, dogs, and pigs [1]. The bacterium expresses adhesins such as filamentous hemagglutinin and pertactin, as well as a bifunctional adenylate cyclase toxin that impairs phagocyte function [2]. In cats, *B. bronchiseptica* can act as a primary pathogen, particularly in overcrowded shelter environments, causing tracheobronchitis and rhinitis [3]. Transmission occurs via aerosol droplets and direct contact, with a carrier state established in recovered animals [1].
### Chlamydia felis
*Chlamydia felis* is an obligate intracellular Gram-negative bacterium that targets conjunctival epithelial cells [2]. It is a leading cause of feline conjunctivitis, often presenting with chemosis, serous to mucopurulent ocular discharge, and blepharospasm [1, 2]. Nasal involvement is less common but can occur in co-infections. *C. felis* is zoonotically limited, with rare reports of conjunctivitis in immunocompromised humans [3].
### Mycoplasma felis
*Mycoplasma felis* is a cell wall‑deficient, facultative intracellular bacterium that attaches to respiratory epithelial surfaces and red blood cells [2]. It is frequently isolated from the upper respiratory tract and conjunctiva of cats, especially in crowded settings [1]. Clinical signs include sneezing, nasal discharge, and conjunctivitis. *M. felis* is often a co‑pathogen with FHV‑1 or FCV [3].
### Other Bacterial Species
*Streptococcus equi* subsp. *zooepidemicus* is a Gram‑positive coccus that can cause severe necrotizing tracheitis and pneumonia in cats, often with systemic dissemination [1]. *Pasteurella multocida*, a commensal of the feline oropharynx, may become pathogenic following mucosal damage [2]. Anaerobic bacteria such as *Fusobacterium* and *Porphyromonas* species contribute to chronic sinusitis and abscessation [3].
## Epidemiology and Risk Factors
Bacterial URI in cats is strongly associated with high-density housing conditions: animal shelters, breeding catteries, and multi-cat households [1]. Risk factors include young age (less than 1 year), stress, poor ventilation, concurrent viral infection, and immunosuppression (e.g., [feline immunodeficiency virus](/knowledge/viruses/pet-viruses/feline-immunodeficiency-virus) infection) [2]. The prevalence of *B. bronchiseptica* in shelter populations ranges from 10% to 50%, while *C. felis* approaches 20% in cats with conjunctivitis [3]. *M. felis* is found in up to 30% of cats with upper respiratory signs [1].
## Clinical Signs and Pathology
Clinical presentation varies by pathogen load and host immune status. Common signs include sneezing, ocular and nasal discharge (serous, mucoid, or purulent), conjunctival hyperemia, chemosis, and submandibular lymphadenopathy [1]. *B. bronchiseptica* frequently induces a honking cough due to tracheal involvement [2]. *C. felis* typically triggers severe conjunctivitis with follicular hyperplasia [3]. *S. zooepidemicus* can cause acute onset dyspnea, cyanosis, and sudden death [1].
Pathologically, bacterial infection disrupts the mucociliary escalator, leading to epithelial erosion, submucosal edema, and neutrophilic infiltration [2]. Chronic infection may result in turbinate destruction, nasal polyp formation, and secondary bacterial rhinosinusitis [3].
## Diagnostic Approaches
Accurate diagnosis of bacterial URI in cats requires integration of clinical examination, sample collection, and laboratory testing. The choice of diagnostic test depends on the suspected pathogen, available equipment, and turnaround time.
### Sample Collection
For upper respiratory samples, sterile swabs (polyester or flocked) are used to collect secretions from the nasal cavity, nasopharynx, or conjunctival fornix [1]. Deep nasal flushing or bronchoalveolar lavage may be indicated for lower respiratory involvement [2]. Samples should be placed in appropriate transport media: Modified Stuart’s medium for bacterial culture, universal transport medium for PCR, and cytology fixative for microscopic evaluation [3].
### Cytology
Microscopic examination of stained smears (Diff-Quik, Gram stain) provides immediate, low-cost information [1]. Presence of intracellular bacteria in neutrophils suggests *Chlamydia* (elementary bodies) or *Mycoplasma* [2]. *Bordetella* appears as small Gram‑negative coccobacilli, often extracellular [3].
### Bacterial Culture and Antimicrobial Susceptibility Testing
Aerobic culture on blood agar and [MacConkey agar](/knowledge/diagnostics/microbiology/macconkey-agar-selective-differential-enteric) is standard for isolating *B. bronchiseptica*, *Pasteurella*, enteric rods, and streptococci [1]. *C. felis* requires specialized cell culture and is rarely performed routinely [2]. *Mycoplasma* species require specific media (e.g., Mycoplasma broth) and prolonged incubation [3]. Antimicrobial susceptibility testing (disk diffusion or broth microdilution) guides therapy, especially given rising resistance rates in *B. bronchiseptica* and *E. coli* [1].
### Molecular Diagnostics
Polymerase chain reaction (PCR) has become the gold standard for detecting fastidious or intracellular bacteria [2]. Real‑time PCR assays targeting species‑specific genes (e.g., *flaA* for *B. bronchiseptica*, *16S rRNA* for *Mycoplasma*, *ompA* for *C. felis*) offer high sensitivity and specificity, often within hours [3]. Multiplex PCR panels that simultaneously detect FHV‑1, FCV, and bacterial pathogens are commercially available and increasingly used in practice. For detailed discussion, see the article on [Point-of-Care Molecular Diagnostics for Feline Upper Respiratory Pathogens: FHV-1, FCV, and Bordetella](/knowledge/diagnostics/emerging-tech/point-of-care-molecular-diagnostics-feline-upper-respiratory-fhv1-fcv-bordetella).
### Serology
Serological testing (e.g., ELISA for *C. felis* antibodies) has limited diagnostic utility in individual cats due to high seroprevalence in populations and cross‑reactivity [1]. It is primarily used for epidemiological studies.
### Diagnostic Decision Making
The following mermaid diagram outlines a diagnostic workflow for cats presenting with acute URI.
```mermaid
graph TD
A["Cat with upper respiratory signs"] --> B{"Clinical exam"}
B --> C["Mild signs, no systemic disease"]
B --> D["Severe signs, chronic, or shelter outbreak"]
C --> E["Supportive care, monitor 3-5 days"]
D --> F["Collect samples: nasal/conjunctival swab"]
F --> G["Impression smear for cytology"]
G --> H{"Evidence of intracellular bacteria?"}
H -->|"Yes"| I["PCR for Chlamydia / Mycoplasma"]
H -->|"No"| J["Aerobic culture + PCR panel"]
I --> K["Positive: targeted antimicrobial"]
I --> L["Negative: consider viral triggers"]
J --> M["Culture + susceptibility results"]
M --> N["Adjust antimicrobial therapy"]
N --> O["Recheck clinical response in 7 days"]
```
## Treatment and Antimicrobial Considerations
Empirical antimicrobial therapy is often initiated while awaiting diagnostic results in moderate to severe cases [1]. The choice of drug must target the most likely pathogens and preserve the feline microbiome. Table 1 summarizes recommended antimicrobials.
**Table 1. Recommended Antimicrobials for Bacterial URI in Cats**
| Pathogen | First‑line Drug | Alternative | Duration |
|---------------|----------------|----------------|-----|
| *Bordetella bronchiseptica* | Doxycycline | Azithromycin | 10-14 d |
| *Chlamydia felis* | Doxycycline (topical + oral) | Amoxicillin‑clavulanate | 4 weeks |
| *Mycoplasma felis* | Doxycycline | Enrofloxacin (with caution) | 2 weeks |
| *Streptococcus zooepidemicus*| Amoxicillin‑clavulanate | Cefovecin | 2 weeks |
| *Pasteurella multocida* | Amoxicillin‑clavulanate | Doxycycline | 7-10 d |
Antimicrobial resistance is a growing concern. Methicillin‑resistant staphylococci and multi‑drug resistant *E. coli* have been isolated from feline URI cases, necessitating susceptibility testing [2]. Fluoroquinolones should be reserved for culture‑confirmed resistant infections due to risk of retinal toxicity in cats [3]. For an in‑depth review of antibiogram patterns, see [Feline Upper Respiratory Tract Infections: Bacterial Etiology, Antibiograms, and Novel Therapeutics](/knowledge/bacteria/pet-bacteria/feline-urinary-respiratory-bacterial-etiologies-antibiograms-therapeutics).
## Control and Prevention
In multi‑cat environments, control relies on reducing stress, improving ventilation, and implementing cohort isolation [1]. Vaccination against *B. bronchiseptica* (intranasal) and *C. felis* (parenteral) is available but not universally recommended; it may be indicated in high‑risk shelters [2]. Routine cleaning with disinfectants effective against Gram‑negative bacteria and *Chlamydia* (e.g., accelerated hydrogen peroxide, bleach solution) is essential [3]. Recovered cats can remain carriers and should be segregated from naive populations. For public health considerations, see [Feline Upper Respiratory Infections: Zoonotic Potential and Public Health](/knowledge/bacteria/pet-bacteria/feline-upper-respiratory-infections-zoonotic-potential-public-health).
## Conclusion
Bacterial pathogens play a critical role in the pathogenesis and persistence of [feline upper respiratory infections](/knowledge/bacteria/pet-bacteria/feline-upper-respiratory-infections-causes-transmission-zoonotic-risk). A systematic diagnostic approach incorporating cytology, culture, and molecular testing allows targeted therapy and reduces unnecessary antimicrobial use. The emergence of resistant strains underscores the need for routine susceptibility testing and adherence to evidence‑based treatment protocols. Clinicians managing [[cat bacterial respiratory infection](/knowledge/bacteria/pet-bacteria/bacterial-respiratory-infections-cats)] cases should integrate laboratory diagnostics with environmental management to optimize outcomes.
## References
[1] Greene CE, Sykes JE. Infectious Diseases of the Dog and Cat. 4th ed. St. Louis: Elsevier; 2012.
[2] Lappin MR. Feline Internal Medicine. 7th ed. St. Louis: Elsevier; 2020.
[3] Merck & Co. The Merck Veterinary Manual. 11th ed. Kenilworth: Merck Sharp & Dohme Corp.; 2016.
## Related Clinical & Scientific Guides
* [Duck Diseases: A Comprehensive Overview for Veterinary Practitioners](/knowledge/bacteria/general/duck-diseases-comprehensive-overview-veterinary)
* [Salmonella Dublin in Cattle: Emerging Pathogen, Diagnostic Challenges, and Public Health Impact](/knowledge/bacteria/general/salmonella-dublin-cattle-emerging-pathogen-diagnostic-public-health)
* [Mycoplasma Infections in Poultry: Vaccination Strategies and Control Programs](/knowledge/bacteria/general/mycoplasma-infections-in-poultry-vaccination-strategies-and-control-programs)